Cannon Fodder Is King [Quick Transmigration]

Chapter 28

　On March 10th, Meng Zezhi received several photos sent by representatives from pharmaceutical companies.

Roche Pharmaceuticals exposed Jiang Qiyang's chaotic private life.

The driver who crashed into Jiang Qiyang's small pickup truck on the highway was arranged by Merck & Co.

Sara, who drugged Jiang Qiyang, was acting on behalf of Johnson & Johnson, and now they had the person in their hands.

Novartis AG fabricated evidence of Jiang Qiyang's drug trafficking and tax evasion. The Los Angeles Police Department has issued a wanted warrant for the "missing" Jiang Qiyang.

Meng Zezhi looked at the photos in his hand. In the basement, Jiang Qiyang, who had been in a coma, had his mouth stuffed with a rag and his body tightly bound with ropes, with two splints casually tied to his left leg.

Indeed, the hearts of capitalists are dark.

However, he liked it.

So the next day, Meng Zezhi happily met with representatives from these pharmaceutical companies, accompanied by two luxurious legal teams supported by the government and Capital University.

Upon arriving at the venue, a conference room large enough to accommodate three hundred people was crowded with people of different skin colors and nationalities.

When Meng Zezhi and the others entered, the previously noisy conference room suddenly quieted down.

"Ahem—"

Meng Zezhi tested the microphone and then looked at the three hundred pairs of eyes below the stage, saying, "I believe everyone is eager to get started, so I won't waste any more time. Let's get straight to the point!"

"First, my basic requirement is a signing fee of 3 billion dollars."

This was basic security.

Upon hearing this, no one in the room moved.

Compared to tens of billions of dollars in pure profit, what was 3 billion in signing fees?

　　At this moment, those who dared to sit here were most afraid not of Meng Zezhi's conditions, but of having money in hand and being unable to spend it.

"Second, after the launch of the specific drug, it should be prioritized for AIDS patients in China, and the price of one set of medication should not exceed $50,000."

Upon hearing this, the pharmaceutical representatives and their assistants below the stage immediately began to communicate.

According to official statistics, there are a total of 700,000 AIDS patients in China, and this is a conservative estimate. In reality, the number of patients may have already exceeded one million.

Assuming there are one million patients, in their expectations, the price of one set of medication should not be less than $200,000 within the first two years of the drug's launch.

This was much higher than Meng Zezhi's estimated price of $100,000.

Only after squeezing the potential of middle-class patient families and considering negotiating price reductions with the national organization later did they set their minimum price line at $50,000.

As for how many AIDS patients would tragically pass away due to lack of effective treatment during this period, and how many would become infected with AIDS, this was not their concern.

Meng Zezhi was never a saint. Otherwise, there wouldn't be this bidding meeting today. All he could do was to mind his own business.

Given the current wealth gap in China, the proportion of AIDS patients capable of affording treatment was expected not to exceed ten percent. If sold directly at $50,000, it meant they would lose at least $15 billion.